Alternative Insulin Delivery Systems
Links shared publicly online about this topic
HCV New Drug Research: Insulin Delivery System Recalled by Roche
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Insulin Delivery System Recalled by Roche” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 30, 2011 at 2:48 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Insulin Delivery System Recalled by Roche http://goo.gl/fb/NnhqH
Roche Insulin Delivery Systems announces recall of ACCU-CHEK® FlexLink Plus infusion sets
fda.gov — “Roche Insulin Delivery Systems announced today that it is notifying its customers and healthcare professionals about the recall of the ACCU-CHEK® FlexLink Plus infusion set, because of the potential for under delivery of insulin due to a kinked/bent cannula when inserting the ACCU-CHEK FlexLink Plus infusion set. If this remains unnoticed, this can result in under delivery leading to elevation of blood glucose levels.” View full resource at fda.gov
Most Recently Shared on February 24, 2011 at 7:11 pm By:
Nephrology News Health News and Nephrology
Roche announces recall of ACCU-CHEK FlexLink Plus infusion sets. http://ow.ly/43zfK
Roche Insulin Delivery Systems Announces Recall of Accu-Chek FlexLink Plus Infusion Sets - American Diabetes Association
diabetes.org — “Roche Insulin Delivery Systems Announces Recall of Accu-Chek FlexLink Plus Infusion Sets - American Diabetes Association” View full resource at diabetes.org
Most Recently Shared on March 7, 2011 at 9:37 pm By:
Important recall: Accu-Chek FlexLink Plus Infusion Sets http://bit.ly/gSMtc2
Roche - Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market
roche.com — “Roche - Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market” View full resource at roche.com
Most Recently Shared on April 13, 2010 at 5:08 am By:
News: Roche acquires Medingo Ltd. and expands its position in the growing insulin delivery systems market http://dlvr.it/V0ZC
Pharmacy Europe - Roche expands its position in the growing insulin delivery systems market
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on April 13, 2010 at 8:48 pm By:
Roche expands its position in the growing insulin delivery systems market http://tinyurl.com/y5j63tg
Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
hindawi.com — “Aim. Inadequately controlled diabetes accounts for chronic complications and increases mortality. Its therapeutic management aims in normal HbA1C, prandial and postprandial glucose levels. This review discusses diabetes management focusing on the latest insulin analogues, alternative insulin delivery systems and the artificial pancreas. Results. Intensive insulin therapy with multiple daily injections (MDI) allows better imitation of the physiological rhythm of insulin secretion. Longer-acting, ” View full resource at hindawi.com
Most Recently Shared on May 26, 2010 at 2:53 pm By:
Endocrinology Wisdom OW Health
Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps: Conclusions. Individualized treat... http://bit.ly/bqZtNl
Valeritas gets $150M boost to market insulin delivery system - Related Stories - AdvaMed SmartBrief
smartbrief.com — “Bridgewater, N.J.-based Valeritas has secured $150 million in a round of Series C funding led by Welsh, Carson, Anderson & Stowe. The company will use the proceeds to market its V-Go delivery system, a disposable device already cleared in the U.S. and Europe that can administer basal bolus insulin …” View full resource at smartbrief.com
Most Recently Shared on September 15, 2011 at 5:37 pm By:
Valeritas gets $150M boost to #market #insulin delivery system http://t.co/PMwsmna0
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial : The Lancet
thelancet.com — “Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. By - Dr Roman Hovorka PhD, Janet M Allen RN, Daniela Elleri MD, Ludovic J...” View full resource at thelancet.com
Most Recently Shared on February 5, 2010 at 8:38 pm By:
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes (Lancet) http://tinyurl.com/yffl7a4
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial : The Lancet
thelancet.com — “Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. By - Dr Roman Hovorka PhD, Janet M Allen RN, Daniela Elleri MD, Ludovic J...” View full resource at thelancet.com
Most Recently Shared on February 5, 2010 at 9:08 pm By:
Gannett Healthcare Health News
Insulin Study Could Lead to New Dosage Devices: http://bit.ly/cWuwyd
Closed-loop insulin delivery improved glucose control, reduced hypoglycemia risk for children
endocrinetoday.com — “An artificial pancreas closed-loop insulin system led to greater reductions in the risk for nocturnal hypoglycemia when compared with continuous” View full resource at endocrinetoday.com
Most Recently Shared on February 8, 2010 at 5:35 pm By:
Closed-loop insulin delivery improved glucose control, reduced hypoglycemia risk for children http://ow.ly/156yw
OmniPod Insulin Management System - Investor Relations - Press Release
phx.corporate-ir.net — “Founded in August 2000, Insulet Corporation is a privately-held, innovative diabetes management company. Insulet Corporation's first commercial product--the OmniPod(tm) Insulin Management System--has been designed to revolutionize the way diabetes is treated and make intensive insulin therapy easier than ever. The System combines the proven healthcare benefits of continuous subcutaneous insulin delivery with blood glucose monitoring technology in an easy to use, two-part system with no tubing an” View full resource at phx.corporate-ir.net
Most Recently Shared on July 13, 2011 at 5:10 am By:
Personal Medicine in Paducah, Kentucky. Dr Hodge was a featured speaker at the Mayo Clinic's Transform Symposium
in '09 and has been named by Brian Dolan of Mobi Heath News as "The
First iPhone Doctor". She is the author of The Personal Pediatrics Primer for the Progressive Parent.
Dr. Hodge's special interests in pediatrics include nutrition,
prevention and the potential for the internet to strengthen physician
patient relationships. Dr. Hodge is a member of the Health care
Information and Management Systems Society (HIMSS), a Fellow of the
Academy of Pediatrics' Quality and Innovation Network, and a founding
member of the Society for Participatory Medicine. Participatory Medicine
is an emerging group of engaged patients and physicians who believe
that mutual trust and understanding as well as use of media, health IT strengthens the physician patient relationship and provides for better care." /> Natalie Hodge, MD, FAAP Pediatrician, Physician, Active Health Library, and Doctor
OmniPod Insulin Management System - Investor Relations - Press Release http://bit.ly/pJhJCr #justsayin I am meeting with #omnipod today
Roche recalls insulin infusion set
endocrinetoday.com — “Roche Insulin Delivery Systems has recalled the Accu-Chek FlexLink Plus insulin infusion set because of the potential for underdelivery of insul” View full resource at endocrinetoday.com
Most Recently Shared on February 25, 2011 at 3:38 pm By:
Roche recalls #insulin infusion set http://ow.ly/43olV #diabetes
Insulin Innovations :: Diabetes Self-Management
diabetesselfmanagement.com — “New forms of insulin and insulin delivery systems are in development. Which ones could make your life easier, and which don't sound attractive to you?” View full resource at diabetesselfmanagement.com
Most Recently Shared on March 30, 2011 at 8:02 pm By:
Diabetes Self-Mgmt Health Site
#diabetes New forms of insulin and insulin delivery systems are in development. Which ones could make life easier? http://bit.ly/hCucLz
Oramed Pharmaceuticals To Present Results Of An Oral Insulin Administration Study At The Tenth Annual Meeting Of The Diabetes Technology Society
medicalnewstoday.com — “Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that its work entitled Extended exposure to an oral insulin formulation yields decreased i” View full resource at medicalnewstoday.com
Most Recently Shared on October 27, 2010 at 12:44 pm By:
Scott Strumello Patient Expert
Oramed Pharmaceuticals to Present Results of Oral Insulin Admin Study @ 10th Annual Mtg of Diabetes Tech Soc: http://bit.ly/aBi9t8
Young Patients With Type 1 Diabetes: Closed-Loop 'Artificial Pancreas' System Can Improve Blood Sugar Control
medicalnewstoday.com — “An article published Online First and in an upcoming edition of The Lancet reports that the use of 'artificial pancreas' closed-loop insulin delivery systems can improve blood sugar contro” View full resource at medicalnewstoday.com
Most Recently Shared on February 5, 2010 at 12:25 pm By:
Young Patients With Type 1 Diabetes: Closed-Loop 'Artificial Pancreas' System Can Improve Blood Sugar Control http://ow.ly/16vo0v
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Tina Banwart - HepatitisCNewDrugs
-
Nephrology News
Your resource for the latest developments in renal care since 1987.
-
ADATucson
Mission: To prevent and cure diabetes and to improve the lives of all 23.6 million Americans affected by diabetes.
Advertisement
